Closed · RFA-CE-16-003 · CFDA 93.136 · Discretionary

Research on Prescription Opioid Use, Opioid Prescribing, and Associated Heroin Risk.

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$100K-$400K
Award range
Closed
Status
February 15, 2016
Close date
2
Expected awards

The verdict

Research on Prescription Opioid Use, Opioid Prescribing, and Associated Heroin Risk. is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $100,000 -- $400,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

$100K-$400K
award range
Closed
application status
2
expected awards
93.136
CFDA program

Archived opportunity record

Research on Prescription Opioid Use is closed (last close February 15, 2016). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 15, 2016

Posted Nov 20 Closes Feb 15

Est. Total Funding

$1,400,000

Expected Awards

2

Instrument

Cooperative Agreement

Description

The purpose of this research is twofold: to investigate the patterns of prescription opioid pain reliever (OPR) use and misuse and transitions from OPR misuse to heroin use (Priority # 1); and whether OPR prescribing is a risk factor for heroin overdose, and if policies and strategies aimed at curbing inappropriate prescribing are associated with increased or decreased risk for heroin overdose (Priority # 2). Applicants are expected to submit one application to address either the first or second research priority.

Catch-all / unrestricted eligibility mark · RFA-CE-16-003

Grants.gov marks Research on Prescription Opioid Use with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). 54 other Centers for Disease Control and Prevention - ERA listings share this eligibility-code string (8% of 640).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Susan Neurath SFN8@cdc.gov

What to do next

Research on Prescription Opioid Use is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.136 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants